GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Research & Development

Albert Labs International (XCNQ:ABRT) Research & Development : C$0.88 Mil (TTM As of Sep. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Albert Labs International Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Albert Labs International's Research & Development for the three months ended in Sep. 2023 was C$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 was C$0.88 Mil.

Albert Labs International Research & Development Historical Data

The historical data trend for Albert Labs International's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert Labs International Research & Development Chart

Albert Labs International Annual Data
Trend Dec21 Dec22
Research & Development
0.47 1.51

Albert Labs International Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.77 0.11 - -

Albert Labs International Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.88 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Albert Labs International  (XCNQ:ABRT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Albert Labs International Research & Development Related Terms

Thank you for viewing the detailed overview of Albert Labs International's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Albert Labs International Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albert Labs International Corp (XCNQ:ABRT) » Definitions » Research & Development
Comparable Companies
XCNQ:MYND XCNQ:ENBI TSXV:IBO XCNQ:HAVN XCNQ:GTTX XCNQ:MOOD XCNQ:WESA.X TSXV:BTI XCNQ:AGN XCNQ:CURE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
6996, Merritt Avenue, Burnaby, BC, CAN, V5J 4R6
Website
https://www.albertlabs.com
Albert Labs International Corp is a laboratory-based, clinical research and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the help of clinical pathway.

Albert Labs International Headlines

No Headlines